These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 21454620)
1. Mislocalization of the E3 ligase, β-transducin repeat-containing protein 1 (β-TrCP1), in glioblastoma uncouples negative feedback between the pleckstrin homology domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and Akt. Warfel NA; Niederst M; Stevens MW; Brennan PM; Frame MC; Newton AC J Biol Chem; 2011 Jun; 286(22):19777-88. PubMed ID: 21454620 [TBL] [Abstract][Full Text] [Related]
2. beta-TrCP-mediated ubiquitination and degradation of PHLPP1 are negatively regulated by Akt. Li X; Liu J; Gao T Mol Cell Biol; 2009 Dec; 29(23):6192-205. PubMed ID: 19797085 [TBL] [Abstract][Full Text] [Related]
3. USP1 regulates AKT phosphorylation by modulating the stability of PHLPP1 in lung cancer cells. Zhiqiang Z; Qinghui Y; Yongqiang Z; Jian Z; Xin Z; Haiying M; Yuepeng G J Cancer Res Clin Oncol; 2012 Jul; 138(7):1231-8. PubMed ID: 22426999 [TBL] [Abstract][Full Text] [Related]
4. Interplay between the phosphatase PHLPP1 and E3 ligase RNF41 stimulates proper kinetochore assembly via the outer-kinetochore protein SGT1. Gangula NR; Maddika S J Biol Chem; 2017 Aug; 292(34):13947-13958. PubMed ID: 28696259 [TBL] [Abstract][Full Text] [Related]
5. The mRNA-stabilizing factor HuR protein is targeted by β-TrCP protein for degradation in response to glycolysis inhibition. Chu PC; Chuang HC; Kulp SK; Chen CS J Biol Chem; 2012 Dec; 287(52):43639-50. PubMed ID: 23115237 [TBL] [Abstract][Full Text] [Related]
6. Associations among beta-TrCP, an E3 ubiquitin ligase receptor, beta-catenin, and NF-kappaB in colorectal cancer. Ougolkov A; Zhang B; Yamashita K; Bilim V; Mai M; Fuchs SY; Minamoto T J Natl Cancer Inst; 2004 Aug; 96(15):1161-70. PubMed ID: 15292388 [TBL] [Abstract][Full Text] [Related]
7. PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K/Akt pro-survival pathway in Huntington's disease striatum. Saavedra A; García-Martínez JM; Xifró X; Giralt A; Torres-Peraza JF; Canals JM; Díaz-Hernández M; Lucas JJ; Alberch J; Pérez-Navarro E Cell Death Differ; 2010 Feb; 17(2):324-35. PubMed ID: 19745829 [TBL] [Abstract][Full Text] [Related]
8. WD repeat protein WDR48 in complex with deubiquitinase USP12 suppresses Akt-dependent cell survival signaling by stabilizing PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1). Gangula NR; Maddika S J Biol Chem; 2013 Nov; 288(48):34545-54. PubMed ID: 24145035 [TBL] [Abstract][Full Text] [Related]
9. Centromere protein W interacts with beta-transducin repeat-containing protein 1 and modulates its subcellular localization. Cheon Y; Jeon S; Lee S FEBS Lett; 2016 Dec; 590(24):4441-4452. PubMed ID: 27861801 [TBL] [Abstract][Full Text] [Related]
10. PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma. Molina JR; Agarwal NK; Morales FC; Hayashi Y; Aldape KD; Cote G; Georgescu MM Oncogene; 2012 Mar; 31(10):1264-74. PubMed ID: 21804599 [TBL] [Abstract][Full Text] [Related]
11. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice. Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606 [TBL] [Abstract][Full Text] [Related]
13. SGT1 regulates Akt signaling by promoting beta-TrCP-dependent PHLPP1 degradation in gastric cancer cells. Gao G; Kun T; Sheng Y; Qian M; Kong F; Liu X; Yu Z; Zhang H; Zhang Q; Gu J; Zhang X Mol Biol Rep; 2013 Apr; 40(4):2947-53. PubMed ID: 23440515 [TBL] [Abstract][Full Text] [Related]
14. Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance. Andreozzi F; Procopio C; Greco A; Mannino GC; Miele C; Raciti GA; Iadicicco C; Beguinot F; Pontiroli AE; Hribal ML; Folli F; Sesti G Diabetologia; 2011 Jul; 54(7):1879-87. PubMed ID: 21461637 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes. Jackson TC; Verrier JD; Drabek T; Janesko-Feldman K; Gillespie DG; Uray T; Dezfulian C; Clark RS; Bayir H; Jackson EK; Kochanek PM J Pharmacol Exp Ther; 2013 Nov; 347(2):516-28. PubMed ID: 24023368 [TBL] [Abstract][Full Text] [Related]
16. Attenuation of Tumor Suppressive Function of FBXO16 Ubiquitin Ligase Activates Wnt Signaling In Glioblastoma. Khan M; Muzumdar D; Shiras A Neoplasia; 2019 Jan; 21(1):106-116. PubMed ID: 30530053 [TBL] [Abstract][Full Text] [Related]
17. PHLPPing through history: a decade in the life of PHLPP phosphatases. Grzechnik AT; Newton AC Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677 [TBL] [Abstract][Full Text] [Related]
18. Oncogenic suppression of PHLPP1 in human melanoma. Dong L; Jin L; Tseng HY; Wang CY; Wilmott JS; Yosufi B; Yan XG; Jiang CC; Scolyer RA; Zhang XD; Guo ST Oncogene; 2014 Sep; 33(39):4756-66. PubMed ID: 24121273 [TBL] [Abstract][Full Text] [Related]
19. TRIB2 inhibits Wnt/β-Catenin/TCF4 signaling through its associated ubiquitin E3 ligases, β-TrCP, COP1 and Smurf1, in liver cancer cells. Xu S; Tong M; Huang J; Zhang Y; Qiao Y; Weng W; Liu W; Wang J; Sun F FEBS Lett; 2014 Nov; 588(23):4334-41. PubMed ID: 25311538 [TBL] [Abstract][Full Text] [Related]
20. Depletion of Pleckstrin homology domain leucine-rich repeat protein phosphatases 1 and 2 by Bcr-Abl promotes chronic myelogenous leukemia cell proliferation through continuous phosphorylation of Akt isoforms. Hirano I; Nakamura S; Yokota D; Ono T; Shigeno K; Fujisawa S; Shinjo K; Ohnishi K J Biol Chem; 2009 Aug; 284(33):22155-22165. PubMed ID: 19261608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]